Disability News and Research

RSS

Whole senome sequencing can effectively secure a diagnosis for people with rare diseases

A world-first scientific study, published today in the New England Journal of Medicine, has shown that whole genome sequencing can uncover new diagnoses for people across the broadest range of rare diseases investigated to date and could deliver enormous benefits across the NHS.

10 Nov 2021

Medicare enrollment blitz doesn’t include options to move into Medigap

Medicare's annual open-enrollment season is here and millions of beneficiaries — prompted by a massive advertising campaign and aided by a detailed federal website — will choose a private Medicare Advantage plan.

9 Nov 2021

Milestone study uncovers genetic risk factors for spine osteoarthritis

Scientists from the LKS Faculty of Medicine, The University of Hong Kong (HKUMed), contributing as part of the 'Genetics of Osteoarthritis (GO)' consortium to the world's largest study of over 800,000 individuals, have identified genetic risk factors - variants associated with SOX5 and CHST3 genes, key regulators of the development of the intervertebral discs, to be implicated in spine osteoarthritis (OA).

8 Nov 2021

Alzheimer’s Disease – A Global Response to a Global Challenge

Alzheimer’s Disease remains both a current issue and a future challenge. Levels of the disease in the European Union have been predicted to double from the current estimate of 7,853,705 to 14,298,671 by 2050

From Biophys Ltd. 8 Nov 2021

Unvaccinated? Don’t count on leaving your family death benefits

These days, workers who refuse to get vaccinated against covid-19 may face financial repercussions, from higher health insurance premiums to loss of their jobs.

3 Nov 2021

Early combination treatment achieves clinically inactive disease in children with polyarticular JIA

New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, found that patients started on early, aggressive treatment with a combination of biologic and conventional disease modifying antirheumatic drugs (DMARDs) achieved clinically inactive disease in children with polyarticular juvenile idiopathic arthritis (JIA) more frequently compared to other treatment plans 24 months after starting treatment.

2 Nov 2021

Ethnic and socioeconomic disparities persist among U.S. adults who identify as disabled

A new analysis led by Johns Hopkins Medicine researchers finds that the number of U.S. adults who report they have a disability is 27%, representing 67 million adults, an increase of 1% since the data were last analyzed in 2016.

1 Nov 2021

Neighborhood fast-food environment associated with increased risk of type 2 diabetes

An increasing number of studies suggest a link between a neighborhood's built environment and the likelihood that its residents will develop chronic diseases such as heart disease, type 2 diabetes (T2D), and certain types of cancers.

29 Oct 2021

New application makes it possible to monitor the symptoms of people at risk for psychosis

A team from the UNIGE has developed an application that makes it possible to monitor the frequency and intensity of the symptoms of people at risk for psychosis on a daily basis, in order to be able to adapt their medical follow-up and determine the cause of the appearance of symptoms.

28 Oct 2021

Researchers discover genetic risk variants involved in osteoarthritis

Osteoarthritis is the leading cause of pain and disability worldwide. There is no cure, only pain relief. Patients' joints become inflamed, and they feel creaky and stiff in the morning.

28 Oct 2021

Study finds inadequate guidance and counseling for working-age people living with dementia

The right of working-age people living with dementia to receive adequate and timely guidance and counseling is not realized properly, a new study from the University of Eastern Finland shows.

27 Oct 2021

New UQ-led center focuses on improving health and economic costs after road traffic injuries

Improving health and economic costs after road traffic injuries is the focus of a new University of Queensland-led Centre of Research Excellence awarded $2.5 million by the National Health and Medical Research Council.

26 Oct 2021

‘Smart bandage’ could help doctors to monitor chronic wounds more easily

How can doctors make sure a dressed wound is healing without taking off the bandage? This is a conundrum, because removing a bandage can disrupt the healing process.

25 Oct 2021

Scientists show how cold could alleviate multiple sclerosis symptoms

In evolutionary biology, the "Life History Theory", first proposed in the 1950s, postulates that when the environment is favorable, the resources used by any organism are devoted for growth and reproduction.

25 Oct 2021

Breastfeeding may positively impact postmenopausal women's cognitive performance

A new study led by researchers at UCLA Health has found that women over the age of 50 who had breastfed their babies performed better on cognitive tests compared to women who had never breastfed.

22 Oct 2021

New smartphone app provides point-of-care treatment algorithms for major depression

Columbia Psychiatry faculty in partnership with avoMD a next-gen clinical decision support platform, have developed an interactive smartphone application that provides point-of-care treatment algorithms for major depression.

21 Oct 2021

Study analyzes neural correlates of balance in individuals with traumatic brain injury

Using neuroimaging techniques and electroencephalography (EEG), Kessler Foundation researchers compared the neural correlates of balance in individuals with traumatic brain injury and matched controls. This study is the first to report EEG-based functional connectivity measures during a balance perturbation task and show the association with white matter integrity in the brain.

21 Oct 2021

Discovery could lead to new treatments for axial spondyloarthritis

In a paper published today in the journal Science Translational Medicine, researchers at the Schroeder Arthritis Institute, part of University Health Network in Toronto, have made a discovery that could lead to new treatments for axial spondyloarthritis (SpA), a painful and debilitating form of arthritis which affects 1-2% of Canadians and causes inflammation in the spine, joints, eyes, gut and skin.

20 Oct 2021

An investigation of three SARS-CoV-2 mRNA doses in multiple sclerosis vaccine non-responders

A clinical study by a team of scientists from Norway aimed to assess the immunogenicity and safety of a third dose of COVID-19 mRNA vaccine in MS patients treated with anti-CD20 therapy or fingolimod. A preprint version of the study, which is yet to undergo peer review, is available on the medRxiv* server.